{"id":51179,"date":"2026-06-26T11:29:09","date_gmt":"2026-06-26T09:29:09","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=51179"},"modified":"2026-06-21T09:33:51","modified_gmt":"2026-06-21T07:33:51","slug":"pinealons-un-citi-peptidi-salidzinajuma-ar-epitalonu-semaksu-cerebrolysinu-ss-31-un-tesamorelinu","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/lv\/pinealon-a-inne-peptydy-porownanie-z-epitalon-semax-cerebrolysin-ss-31-i-tesamorelin\/","title":{"rendered":"Pinoleons un citi pept\u012bdi: sal\u012bdzin\u0101jums ar Epitalonu, Semaksu, Cerebrolysin, SS-31 un Tesamorel\u012bnu"},"content":{"rendered":"

 <\/p>\n

Pinealons un citas pept\u012bdi<\/h2>\n

Palielinoties interesei par pept\u012bdu b\u0101zes intervenc\u0113m, Pinealon bie\u017ei tiek sal\u012bdzin\u0101ts ar vair\u0101kiem labi zin\u0101miem pept\u012bdiem, tostarp Epitalonu, Semax, Cerebrolysin, SS-31 un Tesamorelin. Lai gan \u0161ie savienojumi bie\u017ei tiek apspriesti vien\u0101dos kontekstos, tie iev\u0113rojami at\u0161\u0137iras p\u0113c molekul\u0101r\u0101s strukt\u016bras, biolo\u0123iskajiem m\u0113r\u0137iem, pied\u0101v\u0101tajiem darb\u012bbas meh\u0101nismiem un zin\u0101tnisk\u0101s izp\u0113tes jom\u0101m.<\/p>\n

Pinealons pret Epitalonu<\/h3>\n

Pinealons un Epitalons ir bioregul\u0113jo\u0161i pept\u012bdi, ko izstr\u0101d\u0101jis Vladimirs Havinsons un vi\u0146a kol\u0113\u0123i. Abi bie\u017ei tiek apspriesti saist\u012bb\u0101 ar vesel\u012bgu noveco\u0161anu un p\u0113t\u012bjumiem par ilggad\u012bbu. Tom\u0113r, neskatoties uz \u0161\u012bm l\u012bdz\u012bb\u0101m, t\u0101s ir at\u0161\u0137ir\u012bgas molekulas. Pinealons ir tripept\u012bds, kas sast\u0101v no glutam\u012bnsk\u0101bes, asparaginsk\u0101bes un argin\u012bna (Glu-Asp-Arg; EDR), savuk\u0101rt Epitalons ir tetrapept\u012bds, kas sast\u0101v no alan\u012bna, glutam\u012bnsk\u0101bes, asparaginsk\u0101bes un glic\u012bna (Ala-Glu-Asp-Gly) (1,2).<\/p>\n

Pinealon p\u0113t\u012bjumi galvenok\u0101rt koncentr\u0113j\u0101s uz neiroprotekciju, kognit\u012bvaj\u0101m funkcij\u0101m, oksidat\u012bv\u0101 stresa regul\u0101ciju, neironu dz\u012bvotsp\u0113ju un ar noveco\u0161anos saist\u012bt\u0101m neirolo\u0123isk\u0101m izmai\u0146\u0101m (3\u20138). Eksperiment\u0101lie p\u0113t\u012bjumi ir par\u0101d\u012bju\u0161i, ka Pinealon samazina reakt\u012bvo sk\u0101bek\u013ca sugu (ROS) l\u012bmeni, uzlabo neironu dz\u012bvotsp\u0113ju, palielina seroton\u012bna ekspresiju un aizsarg\u0101 nervu \u0161\u016bnas pret da\u017e\u0101d\u0101m \u0161\u016bnu stresa form\u0101m (4\u20138).<\/p>\n

Savuk\u0101rt p\u0113t\u012bjumi par Epitalonu galvenok\u0101rt koncentr\u0113jas uz noveco\u0161anas biolo\u0123iju, telomer\u0101zes aktivit\u0101ti, melaton\u012bna regul\u0101ciju, diennakts ritmu funkcion\u0113\u0161anu un ar ilgm\u016b\u017e\u012bbu saist\u012btajiem meh\u0101nismiem. Lai gan abi pept\u012bdi tiek klasific\u0113ti k\u0101 geroprotekt\u012bvi bioregulatori, Pinealon parasti tiek uztverts k\u0101 pept\u012bds ar vair\u0101k neirocentrisku iedarb\u012bbu, savuk\u0101rt Epitalon bie\u017e\u0101k tiek saist\u012bts ar visp\u0101r\u0113jiem pretnoveco\u0161an\u0101s p\u0113t\u012bjumiem un epif\u012bzes funkcion\u0113\u0161anu.<\/p>\n

T\u0101 k\u0101 abi pept\u012bdi var ietekm\u0113t at\u0161\u0137ir\u012bgus biolo\u0123iskos ce\u013cus, da\u017ei p\u0113tnieki un pept\u012bdu lietot\u0101ji uzskata pinealonu un epitalonu par potenci\u0101li papildino\u0161iem savienojumiem. Tom\u0113r kontrol\u0113ti kl\u012bniskie p\u0113t\u012bjumi, kas nov\u0113rt\u0113 to vienlaic\u012bgu lieto\u0161anu, ir \u013coti ierobe\u017eoti, un l\u012bdz \u0161im nav veikti lieli cilv\u0113ku p\u0113t\u012bjumi, kas apstiprin\u0101tu \u0161\u0101das pieejas dro\u0161umu vai efektivit\u0101ti.<\/p>\n

Pinealons pret Semaksu<\/h3>\n

Pinealons un Semax bie\u017ei tiek sal\u012bdzin\u0101ti, jo abi ir p\u0113t\u012bti attiec\u012bb\u0101 uz neiroprotekciju un kognit\u012bvo funkciju atbalstu. Tom\u0113r tie pieder piln\u012bgi at\u0161\u0137ir\u012bg\u0101m pept\u012bdu dzimt\u0101m.<\/p>\n

Pinealons ir \u012bss bioregul\u0113jo\u0161s tripept\u012bds (Glu-Asp-Arg), savuk\u0101rt Semax ir sint\u0113tisks adrenokortikotrop\u0101 hormona ACTH(4-10) analogs, kas izstr\u0101d\u0101ts Krievij\u0101 neirolo\u0123iskiem lietojumiem (9,10).<\/p>\n

Pieejamie dati liecina, ka Pinealon nodro\u0161ina daudzas no sav\u0101m biolo\u0123iskaj\u0101m ietekm\u0113m, regul\u0113jot oksidat\u012bvo stresu, epigen\u0113tiskos meh\u0101nismus, g\u0113nu ekspresijas modul\u0101ciju, mijiedarb\u012bbu ar seroton\u012bna ce\u013ciem un atbalstot neironu izdz\u012bvo\u0161anu (4\u20138). Savuk\u0101rt p\u0113t\u012bjumi par Semax galvenok\u0101rt koncentr\u0113j\u0101s uz neirotrofisko aktivit\u0101ti, neirotransmitera sist\u0113mu modul\u0101ciju, neiroprotekciju p\u0113c i\u0161\u0113miskiem boj\u0101jumiem un kognit\u012bvo funkciju uzlabo\u0161anu (9,10).<\/p>\n

Lai gan abi pept\u012bdi tiek p\u0113t\u012bti smadze\u0146u vesel\u012bbai un kognit\u012bvaj\u0101m funkcij\u0101m, Semax p\u0113t\u012bjumi galvenok\u0101rt uzsver neirotrofiskos un neirotransmitera saist\u012btos efektus, savuk\u0101rt Pinealon p\u0113t\u012bjumi vair\u0101k koncentr\u0113jas uz \u0161\u016bnu aizsardz\u012bbu, noveco\u0161an\u0101s biolo\u0123iju, oksidat\u012bv\u0101 stresa mazin\u0101\u0161anu un epigen\u0113tisko regul\u0101ciju.<\/p>\n

Pa\u0161laik nav veikti tie\u0161i kl\u012bniskie p\u0113t\u012bjumi, kas sal\u012bdzin\u0101tu Pinealon un Semax cilv\u0113kiem.<\/p>\n

Pinealons pret Cerebrolysinu<\/h3>\n

Cerebrolysin iev\u0113rojami at\u0161\u0137iras no Pinealon gan sast\u0101va, gan sare\u017e\u0123\u012bt\u012bbas zi\u0146\u0101. Pinealon sast\u0101v no viena sint\u0113tiska tripept\u012bda, savuk\u0101rt Cerebrolysin ir sare\u017e\u0123\u012bts zemo molekulmasu neiropept\u012bdu un aminosk\u0101bju fragmentu mais\u012bjums, kas ieg\u016bts no c\u016bku smadze\u0146u audiem.<\/p>\n

P\u0113t\u012bjumi par Cerebrolysin galvenok\u0101rt koncentr\u0113j\u0101s uz atvese\u013co\u0161anos p\u0113c insulta, traumatiskiem smadze\u0146u boj\u0101jumiem, vaskul\u0101ru demenci un Alcheimera slim\u012bbu. Savuk\u0101rt p\u0113t\u012bjumi par Pinealon galvenok\u0101rt tika veikti saist\u012bb\u0101 ar neironu aizsardz\u012bbu, iztur\u012bbu pret oksidat\u012bvo stresu, kognit\u012bvaj\u0101m funkcij\u0101m un vesel\u012bgu noveco\u0161anos (3\u20138).<\/p>\n

B\u016btiska at\u0161\u0137ir\u012bba starp \u0161iem savienojumiem ir pieejamo kl\u012bnisko datu apjoms. Cerebrolysin tika izv\u0113rt\u0113ts daudz liel\u0101kos kl\u012bnisko p\u0113t\u012bjumu programm\u0101s nek\u0101 Pinealon. Dati par Pinealon joproj\u0101m ir ierobe\u017eoti un galvenok\u0101rt n\u0101k no prekl\u012bniskiem p\u0113t\u012bjumiem un sal\u012bdzino\u0161i nelieliem kl\u012bniskiem p\u0113t\u012bjumiem.<\/p>\n

Lai gan abi savienojumi tiek p\u0113t\u012bti attiec\u012bb\u0101 uz to neiroprotekt\u012bvaj\u0101m \u012bpa\u0161\u012bb\u0101m, tie darbojas at\u0161\u0137ir\u012bgos biolo\u0123iskos meh\u0101nismos, un tos nevajadz\u0113tu uzskat\u012bt par savstarp\u0113ji aizst\u0101jamiem.<\/p>\n

Pinealons pret SS-31<\/h3>\n

SS-31 (elamipret\u012bds) ir uz mitohondrijiem v\u0113rsts pept\u012bds, kas izstr\u0101d\u0101ts, lai aizsarg\u0101tu mitohondriju funkciju un samazin\u0101tu oksidat\u012bvos boj\u0101jumus \u0161\u016bn\u0101s. At\u0161\u0137ir\u012bb\u0101 no Pinealon, kas \u0161\u0137ietami ietekm\u0113 g\u0113nu ekspresiju, neironu dz\u012bvotsp\u0113ju, seroton\u012bna sint\u0113zi un \u0161\u016bnu signaliz\u0101cijas ce\u013cus, SS-31 galvenok\u0101rt ietekm\u0113 mitohondriju membr\u0101nas un \u0161\u016bnu bioener\u0123\u0113tiku.<\/p>\n

Abi pept\u012bdi tika p\u0113t\u012bti attiec\u012bb\u0101 uz to sp\u0113ju samazin\u0101t oksidat\u012bvo stresu. Ir par\u0101d\u012bts, ka Pinealon ierobe\u017eo reakt\u012bvo sk\u0101bek\u013ca formu uzkr\u0101\u0161anos un samazina \u0161\u016bnu boj\u0101jumus oksidat\u012bv\u0101 stresa apst\u0101k\u013cos (4,5), savuk\u0101rt p\u0113t\u012bjumos par SS-31 galven\u0101 uzman\u012bba tika piev\u0113rsta mitohondriju darb\u012bbas uzlabo\u0161anai un boj\u0101jumu samazin\u0101\u0161anai, kas radu\u0161ies to disfunkcijas d\u0113\u013c.<\/p>\n

Pa\u0161laik nav veikti tie\u0161i p\u0113t\u012bjumi, kas sal\u012bdzin\u0101tu Pinealon un SS-31.<\/p>\n

Pinealons pret Tesamorelinu<\/h3>\n

Pinealons un Tesamorelinis pieder pie piln\u012bgi at\u0161\u0137ir\u012bg\u0101m pept\u012bdu kategorij\u0101m un tika p\u0113t\u012bti piln\u012bgi at\u0161\u0137ir\u012bgiem biolo\u0123iskajiem m\u0113r\u0137iem.<\/p>\n

Pinealons ir \u0101rstniecisks neirore\u0123enerat\u012bvs tripept\u012bds, ko galvenok\u0101rt p\u0113t\u012b saist\u012bb\u0101 ar neiroprotekciju, kognit\u012bvaj\u0101m funkcij\u0101m, oksidat\u012bv\u0101 stresa regul\u0101ciju un vesel\u012bgu noveco\u0161anos (3\u20138). Savuk\u0101rt tesamorelins ir aug\u0161anas hormonu atbr\u012bvojo\u0161\u0101 hormona (GHRH) analogs, kas stimul\u0113 endog\u0113n\u0101 aug\u0161anas hormona sekr\u0113ciju un palielina insul\u012bnam l\u012bdz\u012bg\u0101 aug\u0161anas faktora-1 (IGF-1) ra\u017eo\u0161anu.<\/p>\n

P\u0113t\u012bjumi par Tesamorelin galvenok\u0101rt koncentr\u0113j\u0101s uz viscer\u0101lo tauku samazin\u0101\u0161anu, \u0137erme\u0146a sast\u0101vu, vielmai\u0146as vesel\u012bbu un ar aug\u0161anas hormonu saist\u012bto fiziolo\u0123iju. Savuk\u0101rt p\u0113t\u012bjumi par Pinealon koncentr\u0113j\u0101s uz neironu aizsardz\u012bbu, m\u0101c\u012b\u0161anos un atmi\u0146u, seroton\u012bna ekspresiju un ar noveco\u0161anos saist\u012btiem \u0161\u016bnu meh\u0101nismiem.<\/p>\n

\u0160o iev\u0113rojamo meh\u0101nisko at\u0161\u0137ir\u012bbu d\u0113\u013c jaut\u0101jums \u201eTesamorelin vai Pinealon?\u201d nav tie\u0161s sal\u012bdzin\u0101jums. Abi pept\u012bdi tiek p\u0113t\u012bti da\u017e\u0101diem zin\u0101tniskiem m\u0113r\u0137iem un ietekm\u0113 at\u0161\u0137ir\u012bgas fiziolo\u0123isk\u0101s sist\u0113mas.<\/p>\n

Visp\u0101r\u0113js Zin\u0101tniskais Skat\u012bjums<\/h2>\n

Pinealon izce\u013cas starp daudziem pla\u0161i apspriestiem pept\u012bdiem ar t\u0101 neiroprotekt\u012bvo, antioksidantu, epigen\u0113tisko un geroprotekt\u012bvo \u012bpa\u0161\u012bbu kombin\u0101ciju. Pa\u0161reiz\u0113jie dati liecina, ka Pinealon var atbalst\u012bt neironu dz\u012bvotsp\u0113ju, ierobe\u017eot oksidat\u012bvo stresu, ietekm\u0113t ar seroton\u012bnu saist\u012btos ce\u013cus un regul\u0113t ar noveco\u0161anos un neiroprotekciju saist\u012bt\u0101s \u0161\u016bnu funkcijas.<\/p>\n

Tom\u0113r tie\u0161i kl\u012bniskie p\u0113t\u012bjumi, kas sal\u012bdzina Pinealon ar citiem pept\u012bdiem, joproj\u0101m ir \u013coti ierobe\u017eoti. T\u0101p\u0113c pa\u0161laik nav iesp\u0113jams izdar\u012bt nek\u0101dus gal\u012bgus secin\u0101jumus par atsevi\u0161\u0137u savienojumu relat\u012bvo efektivit\u0101ti, dro\u0161umu vai priek\u0161roc\u012bb\u0101m. Nepiecie\u0161ami papildu, labi izstr\u0101d\u0101ti cilv\u0113ku p\u0113t\u012bjumi, lai lab\u0101k raksturotu \u0161o pept\u012bdu l\u012bdz\u012bbas un at\u0161\u0137ir\u012bbas.<\/p>\n

Atruna<\/h3>\n

Teksts ir tikai informat\u012bvs un izgl\u012btojo\u0161s, un to nevajadz\u0113tu interpret\u0113t k\u0101 medic\u012bnisku padomu, diagnozi, \u0101rst\u0113\u0161anu vai profesion\u0101lu ieteikumu. Pinealons, Epitalons, Semax, Cerebrolysin, SS-31 un Tesamorelin b\u016btiski at\u0161\u0137iras p\u0113c strukt\u016bras, darb\u012bbas meh\u0101nismiem un zin\u0101tnisk\u0101s izp\u0113tes jom\u0101m. Amerikas Savienoto Valstu P\u0101rtikas un Z\u0101\u013cu P\u0101rvalde (FDA), Eiropas Z\u0101\u013cu a\u0123ent\u016bra (EMA) vai vairums citu regulat\u012bvo iest\u0101\u017eu nav apstiprin\u0101ju\u0161as Pinealonu, lai \u0101rst\u0113tu neirolo\u0123iskus trauc\u0113jumus, kognit\u012bvus trauc\u0113jumus, ar noveco\u0161anos saist\u012btus st\u0101vok\u013cus vai jebk\u0101dus citus medic\u012bniskus lietojumus. Liela da\u013ca pieejamo datu n\u0101k no prekl\u012bniskiem p\u0113t\u012bjumiem un ierobe\u017eotiem cilv\u0113ku p\u0113t\u012bjumiem. Nepiecie\u0161ami papildu, labi izstr\u0101d\u0101ti kl\u012bniskie p\u0113t\u012bjumi, lai lab\u0101k noteiktu \u0161o pept\u012bdu efektivit\u0101ti, dro\u0161umu un ilgtermi\u0146a efektus, k\u0101 ar\u012b lai noteiktu, vai to starp\u0101 past\u0101v b\u016btiskas at\u0161\u0137ir\u012bbas kl\u012bniskos apst\u0101k\u013cos.<\/p>\n

Atsauces<\/h4>\n
    \n
  1. Pinealon (EDR peptide) \u0137\u012bmija un sast\u0101va dati.<\/span>
    Vikip\u0113dija https:\/\/en.wikipedia.org\/wiki\/Pinealon<\/a><\/span><\/li>\n
  2. Fedorejeva, L. I., Kirejevs, I. I., Khavinsons, V. K., un Vanju\u0161ins, B. F. (2011). \u012asi fluoresc\u0113jo\u0161i iez\u012bm\u0113ti pept\u012bdu iek\u013c\u016b\u0161ana kodol\u0101 HeLa \u0161\u016bn\u0101s un pept\u012bdu specifiska mijiedarb\u012bba in vitro ar deoksiribooligonucleot\u012bdiem un DNS<\/em>. Bio\u0137\u012bmija (Maskava), 76<\/em>(11), 1210\u20131219. https:\/\/doi.org\/10.1134\/S0006297911110022<\/a><\/span>
    \u017durn\u0101la saite:     https:\/\/link.springer.com\/article\/10.1134\/S0006297911110022<\/a><\/span><\/li>\n
  3. Me\u0161\u010daninovs, V. N., Tka\u010denko, E. L., \u017darkovs, S. V., Gavrilovs, I. V., & Katireva, J. E. (2015). Sint\u0113tisko pept\u012bdu ietekme uz pacientu ar hronisku polimorbidit\u0101ti un centr\u0101l\u0101s nervu sist\u0113mas organisko smadze\u0146u sindromu remonta laik\u0101 noveco\u0161anos<\/em>. Gerontolo\u0123ijas sasniegumi, 28<\/em>(1), 62\u201367.<\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/26390612\/<\/a><\/span><\/li>\n
  4. Khavinsons, V., Ribakova, J., u.c. (2011). Pinealon palielina \u0161\u016bnu dz\u012bvotsp\u0113ju, nom\u0101cot br\u012bvo radik\u0101\u013cu l\u012bmeni un aktiviz\u0113jot proliferat\u012bvus procesus<\/em>. Atjauno\u0161an\u0101s p\u0113t\u012bjumu, 14<\/em>(5), 517\u2013523. https:\/\/doi.org\/10.1089\/rej.2011.1172<\/a><\/span>
    \u017durn\u0101la saite:     https:\/\/journals.sagepub.com\/doi\/abs\/10.1089\/rej.2011.1172<\/a><\/span><\/li>\n
  5. Arutjunjan, A. V., Kozina, L. S., Stvolinsky, S. L., Bulygina, E. R., Ma\u0161kina, A. P., & Havinsona, V. K. (2012). Pinealons pasarg\u0101 \u017eurku p\u0113cn\u0101c\u0113jus no pirmsdzemd\u012bbu hiperhomocistein\u0113mijas<\/em>. International Journal of Peptides, 2012<\/em>, 109757. https:\/\/doi.org\/10.1155\/2012\/109757<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/22567179\/<\/a><\/span>
    PMC pilns teksts:     https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3342713\/<\/a><\/span><\/li>\n
  6. Khavinsons, V. K., Lin'kova, N. S., Tarnovska, S. I., Umnovs, R. S., Ela\u0161kina, E. V., & Durnova, A. O. (2014). \u012asi pept\u012bdi stimul\u0113 seroton\u012bna ekspresiju smadze\u0146u garozas \u0161\u016bn\u0101s<\/em>. Biolo\u0123ijas un medic\u012bnas eksperimentu bi\u013cetins, 157<\/em>(1), 77\u201380. https:\/\/doi.org\/10.1007\/s10517-014-2496-y<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/24909721\/<\/a><\/span><\/li>\n
  7. Kraskovska, N. A., Kukanova, E. O., Linkova, N. S., Popugaeva, E. A., & Havinsona, V. K. (2017). Trpept\u012bdi atjauno neironu smaili\u0146u skaitu in vitro model\u0113t\u0101s Alcheimera slim\u012bbas apst\u0101k\u013cos<\/em>. Biolo\u0123ijas un medic\u012bnas eksperimentu bi\u013cetens, 163<\/em>(4), 547\u2013550. https:\/\/doi.org\/10.1007\/s10517-017-3847-2<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/28853087\/<\/a><\/span><\/li>\n
  8. Khavinsona, V., I\u013cina, A., Kraskovska, N., Linkova, N., Kol\u010dina, N., Mironova, E., Jerofejevs, A., & Petuhovs, M. (2021). Neiroprotekt\u012bv\u0101 ietekme tripept\u012bdiem \u2014 epigen\u0113tiskiem regulatoriem Alcheimera slim\u012bbas peles model\u012b<\/em>. Farmaceitikas, 14<\/em>(6), 515. https:\/\/doi.org\/10.3390\/ph14060515<\/a><\/span>
    \u017durn\u0101la saite:     https:\/\/www.mdpi.com\/1424-8247\/14\/6\/515<\/a><\/span><\/li>\n
  9. Tsai, S. J. (2007). Semaks, adrenokortikotrop\u012bna (4\u201310) analogu, ir potenci\u0101ls l\u012bdzeklis uzman\u012bbas defic\u012bta\/hiperaktivit\u0101tes trauc\u0113jumu un Retta sindroma \u0101rst\u0113\u0161anai<\/em>. Medical Hypotheses, 68<\/em>(5), 1144\u20131146. https:\/\/doi.org\/10.1016\/j.mehy.2006.07.017<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/16996699\/<\/a><\/span><\/li>\n
  10. Dolotovs, O. V., Karpenko, E. A., Inozemtseva, L. S., Seredenina, T. S., Levitskaya, N. G., Rozyczka, J., Dubynina, E. V., Novosadova, E. V., Andreeva, L. A., Alfeeva, L. Y., Kamensky, A. A., Grivennikov, I. A., Myasoedov, N. F., & Engele, J. (2006). Semax, ACTH(4\u201310) analogs ar kognit\u012bvu iedarb\u012bbu, regul\u0113 BDNF un trkB ekspresiju \u017eurku hipokamp\u0101<\/em>. Smadze\u0146u izp\u0113te, 1117<\/em>(1), 54\u201360. https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/<\/a><\/span><\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"

      Pinealon un Inne Peptydy L\u012bdz ar augo\u0161o interesi par uz pept\u012bdiem balst\u012bt\u0101m intervenc\u0113m Pinealon bie\u017ei tiek sal\u012bdzin\u0101ts ar vair\u0101kiem labi paz\u012bstamiem pept\u012bdiem, tostarp Epitalon, Semax,\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[253],"tags":[],"class_list":["post-51179","post","type-post","status-publish","format-standard","hentry","category-kategoria-pinealon","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/51179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/comments?post=51179"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/51179\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/media?parent=51179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/categories?post=51179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/tags?post=51179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}